GED 0507-34-Levo is an orally activePPARγmodulator. GED 0507-34-Levo downregulates the expression ofTGF-β,Smad3,IL-13, andCTGFin the colon. GED 0507-34-Levo improves DSS-induced chronic colitis and fibrosis[1].
References:
[1].Speca S, et al. Novel PPARγ Modulator GED-0507-34 Levo Ameliorates Inflammation-driven Intestinal Fibrosis. Inflamm Bowel Dis. 2016 Feb;22(2):279-92.
















